QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 17, Issue 1, 438-447, January 2006

This Article Full Text Full Text (PDF) All Versions of this Article: E05-07-0612v1 17/1/438    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McKinsey, T. A. Articles by Olson, E. N. Search for Related Content PubMed PubMed Citation Articles by McKinsey, T. A. Articles by Olson, E. N.

Class II Histone Deacetylases Confer Signal Responsiveness to the Ankyrin-Repeat Proteins ANKRA2 and RFXANK

Timothy A. McKinsey ^* , Koichiro Kuwahara  , Svetlana Bezprozvannaya , and Eric N. Olson 

^* Myogen, Westminster, CO 80021; Department of Molecular Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9148

Submitted July 11, 2005; Revised September 24, 2005; Accepted October 7, 2005
Monitoring Editor: Marianne Bronner-Fraser

Class II histone deacetylases (HDACs) contain unique amino-terminal extensions that mediate interactions with members of the myocyte enhancer factor-2 (MEF2) family of transcription factors and responsiveness to kinases, including Ca²⁺/calmodulin-dependent kinase (CaMK). Despite intense investigation of class II HDACs, little is known of MEF2-independent mechanisms for transcriptional repression by these chromatin-modifying enzymes. Here, we demonstrate that class II HDACs 4 and 5 physically associate with ankyrin-repeat proteins ANKRA2 and RFXANK (RFX-B/Tvl-1/ANKRA1). ANKRA2 is a megalin- and BKCa potassium channel-interacting factor, whereas RFXANK is a positive regulator of major histocompatibility complex II (MHC II) gene expression. HDAC4 and HDAC5 interact with the ankyrin repeats of ANKRA2 and RFXANK and, through association with RFXANK, repress MHC II promoter activation. HDACs 4 and 5 also repress endogenous HLA-DRA gene expression induced by CIITA. Phosphorylation of class II HDACs by CaMK results in CRM1-dependent nuclear export of HDAC/RFXANK complexes. These results define a novel transcriptional pathway under the control of class II HDACs and suggest a role for these transcriptional repressors as signal-responsive regulators of antigen presentation.

These authors contributed equally to this work.

Address correspondence to: Eric N. Olson (eolson{at}hamon.swmed.edu).

This article has been cited by other articles:

				J. Pang, C. Yan, K. Natarajan, M. E. Cavet, M. P. Massett, G. Yin, and B. C. Berk GIT1 Mediates HDAC5 Activation by Angiotensin II in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 892 - 898. [Abstract] [Full Text] [PDF]

				T. L. Herrmann, R. S. Agrawal, S. F. Connolly, R. L. McCaffrey, J. Schlomann, and D. J. Kusner MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II J. Leukoc. Biol., September 1, 2007; 82(3): 686 - 699. [Abstract] [Full Text] [PDF]

				J. K. Pagan, J. Arnold, K. J. Hanchard, R. Kumar, T. Bruno, M. J. K. Jones, D. J. Richard, A. Forrest, A. Spurdle, E. Verdin, et al. A Novel Corepressor, BCoR-L1, Represses Transcription through an Interaction with CtBP J. Biol. Chem., May 18, 2007; 282(20): 15248 - 15257. [Abstract] [Full Text] [PDF]